Kazia Therapeutics Limited (KZIA)
US Market

Kazia Therapeutics (KZIA) Financial Statements


Kazia Therapeutics Financial Overview

Kazia Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.828; its P/E ratio is -0.54; Kazia Therapeutics is scheduled to report earnings on February 21, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Dec 22Dec 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 5.24MAU$ 4.39MAU$ 15.19MAU$ 19.37MAU$ 8.76M
Total AssetsAU$ 28.09MAU$ 27.84MAU$ 44.67MAU$ 39.61MAU$ 23.06M
Total DebtAU$ 1.80MAU$ 552.32KAU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -3.44MAU$ -3.84MAU$ -15.19MAU$ -19.37MAU$ -8.76M
Total LiabilitiesAU$ 16.03MAU$ 16.25MAU$ 19.18MAU$ 7.94MAU$ 8.94M
Stockholders EquityAU$ 12.05MAU$ 11.58MAU$ 25.49MAU$ 31.68MAU$ 14.13M
Cash Flow-
Free Cash Flow--AU$ -2.69MAU$ -10.04MAU$ -2.75M
Operating Cash Flow-----
Investing Cash Flow--AU$ -278.00--
Financing Cash Flow--AU$ 16.70KAU$ 23.60MAU$ 8.40M
Currency in AUD

Kazia Therapeutics Earnings and Revenue History

Kazia Therapeutics Debt to Assets

Kazia Therapeutics Cash Flow

Kazia Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis